Pe Veränderung Datum
AbbVie 23.96 0.93 2026-06
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
Arrowhead Research 39.19 0 2026-06
AstraZeneca 25.34 4.25 2026-06
Biogen 23.23 9.53 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
J&J 29.43 4.9 2026-06
Merck 32.26 15.74 2026-06
Novartis 22.41 2.24 2026-06
Pfizer 11.48 2.16 2026-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Xencor 29.92 3.22 2022-09